SMA Medication Zolgensma May Cause Liver Failure, Warns New Label Update | mySMAteam

Connect with others who understand.

sign up Log in
Resources
About mySMAteam
Powered By
SMA
NEWS

SMA Medication Zolgensma May Cause Liver Failure, Warns New Label Update

Medically reviewed by Amit M. Shelat, D.O.
Written by Maureen McNulty
Posted on November 30, 2021

  • Zolgensma (onasemnogene abeparvovec-xioi), a treatment for children with spinal muscular atrophy (SMA), can sometimes lead to liver problems.
  • The liver problems are usually mild, but in rare cases may be severe.
  • Zolgensma’s label has been updated to indicate that when children with SMA take this treatment, they need to first undergo liver tests and should take corticosteroids before and after Zolgensma infusion.

New research suggests that Zolgensma — used to treat children with SMA — can cause liver damage and liver failure in rare instances. This revelation has prompted the U.S. Food and Drug Administration (FDA) to change the drug’s label to alert people about the potential side effects.

Zolgensma is a type of gene therapy that acts to correct the gene mutations that cause SMA. Zolgensma spurs neurons into making more SMN protein, which helps correct SMA symptoms like muscle weakness and breathing problems. A recent study found that children with SMA type 1 benefited from being treated with Evrysdi (risdiplam) after one-time treatment with Zolgensma

Share your thoughts with others. Click here to add a comment.

The FDA first approved Zolgensma in May 2019. This treatment, which is given as a one-time IV infusion, can be taken by children under 2 with SMA.

The FDA continues to monitor treatments after initially approving them to see whether they cause any side effects. The FDA recently updated Zolgensma’s label to include a boxed warning about potential liver problems. The warning states that the treatment can cause:

  • Increased levels of liver enzymes, including aspartate aminotransferase, alanine aminotransferase, and bilirubin
  • Liver damage
  • Liver failure

How Does Zolgensma Affect the Liver?

These liver problems were reported in a recent study published by Novartis, the maker of Zolgensma. In this study, researchers collected data from 100 children who took part in Zolgensma clinical trials.

Tests showed that 90 out of 100 of the children had higher-than-normal levels of liver enzymes. In most cases, levels were increased only slightly. Additionally, 61 out of 100 children had increased liver enzymes before they were given Zolgensma, meaning that they may have had some preexisting liver problems before being treated.

For most children in Zolgensma clinical trials, liver enzyme levels returned to normal within two months. However, high enzyme levels can sometimes progress to worse liver problems. Out of 43 children treated with Zolgensma outside of clinical trials, two developed liver injury, which was successfully treated. One additional child was diagnosed with liver failure and required a liver transplant.

Ways To Prevent Liver Damage

Doctors usually administer corticosteroid medications, such as prednisolone, along with Zolgensma. Giving steroids before and after treatment can help prevent liver damage from the gene therapy.

Additionally, the new warning on the Zolgensma label recommends that doctors perform blood tests to examine how well the liver is working before giving the treatment. If a child has preexisting signs of liver damage, they may be more likely to experience liver-related side effects after taking Zolgensma. In some cases, doctors may recommend children with preexisting liver problems do not receive Zolgensma.

Posted on November 30, 2021
All updates must be accompanied by text or a picture.

Become a Subscriber

Get the latest news about spinal muscular atrophy sent to your inbox.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Amit M. Shelat, D.O. is a fellow of the American Academy of Neurology and the American College of Physicians. Review provided by VeriMed Healthcare Network. Learn more about him here
Maureen McNulty studied molecular genetics and English at Ohio State University. Learn more about her here

Recent Articles

Welcome to mySMAteam — the place to connect with others living with spinal muscular atrophy. Thi...

Getting Started on mySMAteam (VIDEO)

Welcome to mySMAteam — the place to connect with others living with spinal muscular atrophy. Thi...
If you’re living with spinal muscular atrophy (SMA), you can have a happy and healthy pregnancy, ...

6 Facts About Pregnancy With SMA

If you’re living with spinal muscular atrophy (SMA), you can have a happy and healthy pregnancy, ...
Magnetic resonance imaging (MRI) is a powerful imaging technique for visualizing the muscles, org...

Can MRI Detect Spinal Muscular Atrophy?

Magnetic resonance imaging (MRI) is a powerful imaging technique for visualizing the muscles, org...
If you or a loved one is living with spinal muscular atrophy (SMA), you may be researching to lea...

SMA and ALS: 5 Differences and 3 Similarities

If you or a loved one is living with spinal muscular atrophy (SMA), you may be researching to lea...
If your child was recently diagnosed with spinal muscular atrophy (SMA) — or if you were recently...

Can You Walk With Spinal Muscular Atrophy? 4 Things To Know

If your child was recently diagnosed with spinal muscular atrophy (SMA) — or if you were recently...
This is a short guided meditation by Dr. Christiane Wolf on self-kindness, which gives you more s...

Self-Kindness When Struggling: 6-Minute Guided Meditation

This is a short guided meditation by Dr. Christiane Wolf on self-kindness, which gives you more s...
SMA News
SMA News

Thank you for subscribing!

Become a member to get even more:

sign up for free

close